Policy and partnerships. Innovation and investment. Access and awareness. Mid-Atlantic Bio: at the epicenter of bioscience R&D, capital and policy.
Mid-Atlantic Bio is the premier regional biotech conference for senior-level executives, policymakers, academia, financiers, media and service providers. First launched in 2005, the conference is a joint initiative of the founding host organizations: the Mid-Atlantic Venture Association, the Virginia Biotechnology Association, and the Technology Council of Maryland. The Conference is also pleased to welcome the North Carolina Biotechnology Center as a Strategic Partner for 2012.
Drawing attendance from leading industry clusters and centers of excellence – both in and outside the region’s footprint – the 2012 Mid-Atlantic Bio conference will bring together a critical mass of key industry stakeholders and create an ideal forum to impact the business, policy and financial climates so imperative to innovation.
For two days, attendees will engage in policy discussions, educational workshops, partnering and business development meetings, investor presentations, media briefings, and innovation exhibitions.
Whether you need to finance, partner or license technology, Mid-Atlantic Bio introduces you to key decision-makers. Join more than 1,000 industry stakeholders – representing 30 states and 10 countries – for the 2012 Mid-Atlantic Bio Conference, September 27th -28th, in Bethesda, MD. Click here for pictures from past events.
For attendees, partners, sponsors and exhibitors, Mid-Atlantic Bio provides entrée to a captive audience of critical stakeholders. For the industry and the region, it is an opportunity to demonstrate biotechnology as a solution to heal, feed and fuel the world, promote sound policy, and inform key constituencies about the value of innovation and the impact made – in our lives, in our states, across the country and around the world.
Latest News
- North Carolina Joins Mid-Atlantic Bio As Strategic Partner – Mar 08, 2012
- Baltimore-Based CSA Medical Raises $20.5 Million in Second Round – Feb 21, 2012
- Baltimore-Based CSA Medical Raises $12.6 Million in First Round – Feb 21, 2012
- Blacksburg-Based Intrexon Raises $100 Million in Fifth Round – Feb 21, 2012
- Rockville-Based Supernus Raises $42 Million to Prepare Drugs for Launch – Feb 21, 2012
Event Partners
Three of the region's most influential bioscience and investor associations—The Mid-Atlantic Venture Association, the Virginia Biotechnology Association and the Tech Council Of Maryland — have joined forces again to co-host a one-of-a-kind event for those in the life sciences community.
